The meeting will include breakfast, a company update from ViewRay management, and a presentation from M Salim U Siddiqui, MD, PhD, Department of Radiation Oncology at Henry Ford Cancer Institute. Dr. Siddiqui will discuss clinical experiences at Henry Ford Cancer Center with the world's first FDA-Cleared MRI guided linear accelerated-based radiation therapy system.
Event: ViewRay Analyst & Investor MeetingDate: Monday, September 25, 2017 Time: 7:00 – 8:30 a.m. PTLocation: Marriott Marquis, 333 W Harbor Dr. San Diego, CA, South Tower, Level 3
An audio webcast of the presentation will be available on the investor relations section of ViewRay's website at www.viewray.com. A replay of the webcast will be available for 90 days after the date of the presentation.
To attend the live event, please RSVP to Brian Johnston at [email protected].
About ViewRayViewRay®, Inc. (Nasdaq: VRAY) designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors during radiation. ViewRay believes this combination of enhanced visualization and accuracy will significantly improve outcomes for patients.
ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
View original content:http://www.prnewswire.com/news-releases/viewray-to-host-analyst--investor-meeting-at-astro-in-san-diego-300523050.html
SOURCE ViewRay, Inc.
